Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2110-5820
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans? ; volume:8 ; number:1 ; day:27 ; month:9 ; year:2018 ; pages:1-3 ; date:12.2018
Annals of intensive care ; 8, Heft 1 (27.9.2018), 1-3, 12.2018
- Creator
-
Honore, Patrick M.
- Contributor
-
Bels, David De
Spapen, Herbert D.
SpringerLink (Online service)
- DOI
-
10.1186/s13613-018-0431-5
- URN
-
urn:nbn:de:101:1-2018111022161679688866
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Honore, Patrick M.
- Bels, David De
- Spapen, Herbert D.
- SpringerLink (Online service)
Other Objects (12)
Oxidative stress markers and septic acute kidney injury: Novel research avenue or road to nowhere?
Passive leg raising test with minimally invasive monitoring: the way forward for guiding septic shock resuscitation?
Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?
Renal protection in sepsis: Is hypertonic sodium (lactate) the solution?
Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients
Normal saline as resuscitation fluid in critically ill patients: not dead yet!
CytoSorb removes MDMA in vitro, but is it an effective therapy in vivo?
VCO2 calorimetry: stop tossing stones, it’s time for building!
Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not
Study claiming target in sepsis with erythromycin has no effect upon mortality and secondary outcomes includes patients with CRRT and RRT
Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous veno-venous hemofiltration
Correction to: Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous venovenous hemofiltration
Oxidative stress markers and septic acute kidney injury: Novel research avenue or road to nowhere?
Passive leg raising test with minimally invasive monitoring: the way forward for guiding septic shock resuscitation?
Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?
Renal protection in sepsis: Is hypertonic sodium (lactate) the solution?
Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients
Normal saline as resuscitation fluid in critically ill patients: not dead yet!
CytoSorb removes MDMA in vitro, but is it an effective therapy in vivo?
VCO2 calorimetry: stop tossing stones, it’s time for building!
Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not
Study claiming target in sepsis with erythromycin has no effect upon mortality and secondary outcomes includes patients with CRRT and RRT
Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous veno-venous hemofiltration
Correction to: Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous venovenous hemofiltration
Oxidative stress markers and septic acute kidney injury: Novel research avenue or road to nowhere?
Passive leg raising test with minimally invasive monitoring: the way forward for guiding septic shock resuscitation?
Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?
Renal protection in sepsis: Is hypertonic sodium (lactate) the solution?
Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients
Normal saline as resuscitation fluid in critically ill patients: not dead yet!
CytoSorb removes MDMA in vitro, but is it an effective therapy in vivo?
VCO2 calorimetry: stop tossing stones, it’s time for building!
Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not
Study claiming target in sepsis with erythromycin has no effect upon mortality and secondary outcomes includes patients with CRRT and RRT
Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous veno-venous hemofiltration